Tuberculosis (TB) testing doesn't work the way many people think. These tests don't show whether you currently have active TB disease—at least not in the way a COVID-19 test shows an active infection. Instead, TB tests reveal whether your immune system has encountered the TB bacteria, called Mycobacterium tuberculosis. This distinction matters because it shapes which test you might receive and what the results mean for your next steps.
Learn About Paying Your FGUA Bill Online →
The bacteria that causes TB spreads through the air when an infected person coughs, sneezes, or speaks. When you inhale these droplets, the bacteria can lodge in your lungs. Your immune system responds by developing antibodies and sensitized cells—a state called TB infection. This is different from TB disease. You can have TB infection without ever getting sick, and most people who are infected never develop active disease.
Understanding this difference explains why testing exists: doctors use TB tests to find people who carry the bacteria so they can monitor them and prevent progression to active disease. According to the CDC, about 13 million people in the United States have TB infection without symptoms. Of these, roughly 5-10% will develop active TB disease at some point in their lives, particularly if their immune system weakens.
TB testing serves several practical purposes. Employers may require tests before hiring. Healthcare facilities screen workers and patients. Schools sometimes request tests for students or staff. Public health officials conduct testing during TB outbreaks. Immigration processes include TB screening. Understanding what the test measures—not whether you're currently sick, but whether your body has been exposed—helps you interpret results accurately.
Practical takeaway: A positive TB test means your immune system has encountered TB bacteria. It does not automatically mean you have TB disease or that you're contagious. Further evaluation is needed to determine if you have active disease or just infection.
The tuberculin skin test (TST), also called the Mantoux test, remains one of the most common TB screening methods. A healthcare provider injects a small amount of purified protein derivative (PPD)—a substance derived from TB bacteria—into the skin on your inner forearm, just below the surface. The injection itself feels like a tiny pinch, and the amount injected is so small (0.1 milliliters) that most people barely notice it.
Free Guide to Pay by Plate Illinois Billing →
After the injection, you must wait 48 to 72 hours to return for a reading. During this waiting period, your immune system reacts to the PPD. If you've been exposed to TB bacteria, your immune cells will recognize this substance and cause swelling and hardening at the injection site. The healthcare provider measures this induration—the raised, firm area—in millimeters using a ruler. The measurement is what determines the result, not redness or other visible reactions.
How the results are interpreted depends on several factors: your TB risk level, whether you have symptoms, and your overall health. The CDC provides three interpretation thresholds. An induration of 5 millimeters or more is considered positive for people with HIV, those in close contact with someone with TB disease, or those with chest X-ray findings suggesting TB. For people at higher risk (healthcare workers, immigrants from TB-prevalent countries, homeless individuals), 10 millimeters or more indicates a positive result. For people with no known risk factors, 15 millimeters or more is positive.
Some people receive false results. A false positive can occur if you've received the BCG vaccine, a TB vaccine used in many countries outside the United States. BCG vaccination causes your immune system to react to PPD even if you've never encountered actual TB bacteria. A false negative might happen if your immune system is weakened by HIV, severe malnutrition, or recent TB infection that hasn't yet triggered an immune response. Age also affects results—very young children and elderly individuals sometimes show weaker reactions even with true infection.
Practical takeaway: The TST requires two visits: one for injection and one 48-72 hours later for measurement. Bring a ruler-measurement record with you if you travel between the two appointments, as the timing and proper measurement are critical for accuracy.
Interferon-gamma release assays (IGRAs) represent a newer approach to TB testing that relies on a blood sample rather than a skin injection. These tests measure how your immune cells respond to TB antigens—the specific proteins found in TB bacteria. Two IGRAs are commonly used in the United States: the QuantiFERON-Gold In-Tube test and the T-SPOT.TB test. Both accomplish the same goal through slightly different methods, and both measure your immune system's memory of exposure to TB bacteria.
Free Guide to Mold Removal Methods for Walls →
The blood draw for an IGRA is straightforward. A phlebotomist draws blood into special collection tubes that contain TB antigens. You don't need to fast or prepare in any special way. The blood samples are then sent to a laboratory where technicians expose your immune cells to the TB antigens and measure how much interferon-gamma—a chemical messenger—your cells produce in response. Higher production indicates previous TB exposure. Results are typically available within 24 hours, though some labs may take longer.
IGRAs offer practical advantages over skin tests. They don't require a follow-up appointment—you get your result from a single visit. People with BCG vaccination don't typically show false positives, since IGRAs measure response to TB-specific antigens rather than the broader PPD antigen. IGRAs work better for people who are unlikely to return for the 48-72 hour reading required by skin tests. They're also more reliable in people with weakened immune systems, though severely immunocompromised individuals may still show false negatives.
However, IGRAs have limitations too. Some labs don't offer all IGRA types—availability varies by location. These tests are more expensive than skin tests, which affects who can access them. A small percentage of people receive indeterminate results, meaning the test wasn't conclusive and may need to be repeated or followed by a skin test. Additionally, IGRAs may not be reliable in children younger than five years old, as their immune systems haven't developed sufficiently to mount a strong interferon-gamma response.
Practical takeaway: IGRAs offer a single-visit blood test alternative to skin testing. Ask your healthcare provider whether IGRAs are available in your area and whether your insurance covers them, as cost and access vary significantly.
If a TB skin test or IGRA comes back positive, your next step typically involves a chest X-ray. This imaging test can reveal whether TB bacteria have progressed to active disease in your lungs. Active TB disease often leaves distinctive patterns on X-rays: infiltrates (areas of infection) usually appear in the upper lobes of the lungs, sometimes with cavities that look like hollow spaces within the infected tissue. Radiologists are trained to recognize these patterns, though TB can appear differently depending on your age and immune status.
How to Delete Your Fitbit Account Guide →
A chest X-ray is painless and quick—you stand or sit in front of a machine while it takes images. You'll be asked to hold your breath briefly to reduce motion blur. For pregnant people, the radiation exposure is extremely low and localized to the chest, but you should inform the technician of pregnancy so they can use appropriate shielding. Results typically come back within hours, though busy facilities may take longer.
If a chest X-ray shows findings suggestive of TB, doctors order additional tests to confirm TB disease and identify the specific type of bacteria. A sputum smear test involves coughing mucus into a container; a technician then examines samples under a microscope after staining with special dyes. If acid-fast bacilli (AFB)—the rod-shaped TB bacteria—are visible, you have infectious TB. A TB culture grows bacteria from your sputum sample in a laboratory, which takes 2-4 weeks but allows doctors to test which antibiotics will work against your specific bacteria. Drug sensitivity testing checks whether your TB bacteria resist certain medications, which is critical for treatment planning.
In recent years, rapid molecular tests like GeneXpert MTB/RIF have accelerated diagnosis. These tests detect TB bacterial DNA in sputum within two hours and simultaneously check for rifampicin resistance, a marker for multidrug-resistant TB. The WHO recommends this test as the initial diagnostic test for anyone with TB
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.